SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'CZE'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXE_A_1FLA2002_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 9 / 10 | PHE A 205ALA A 209ALA A 212LEU A 330LEU A 346ALA A 349GLU A 353SER A 479LEU A 480 | NoneCZE A 613 ( 4.4A)CZE A 613 ( 3.7A)CZE A 613 ( 4.2A)CZE A 613 ( 3.8A)CZE A 613 ( 4.7A)CZE A 613 (-2.9A)NoneNone | 0.64A | 2bxeA-5dqfA:46.1 | 2bxeA-5dqfA:76.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXE_B_1FLB2002_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 9 / 11 | PHE A 205ALA A 209ALA A 212LEU A 346ALA A 349LYS A 350GLU A 353SER A 479LEU A 480 | NoneCZE A 613 ( 4.4A)CZE A 613 ( 3.7A)CZE A 613 ( 3.8A)CZE A 613 ( 4.7A)CZE A 613 (-4.1A)CZE A 613 (-2.9A)NoneNone | 0.72A | 2bxeB-5dqfA:48.1 | 2bxeB-5dqfA:76.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXG_A_IBPA2002_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 5 / 8 | ALA A 212ALA A 349GLU A 353SER A 479LEU A 480 | CZE A 613 ( 3.7A)CZE A 613 ( 4.7A)CZE A 613 (-2.9A)NoneNone | 0.76A | 2bxgA-5dqfA:48.9 | 2bxgA-5dqfA:76.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXG_A_IBPA2002_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 5 / 8 | ALA A 349LYS A 350GLU A 353SER A 479LEU A 480 | CZE A 613 ( 4.7A)CZE A 613 (-4.1A)CZE A 613 (-2.9A)NoneNone | 0.87A | 2bxgA-5dqfA:48.9 | 2bxgA-5dqfA:76.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXG_B_IBPB2002_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 7 / 10 | ALA A 209ALA A 212LEU A 330LEU A 346ALA A 349SER A 479LEU A 480 | CZE A 613 ( 4.4A)CZE A 613 ( 3.7A)CZE A 613 ( 4.2A)CZE A 613 ( 3.8A)CZE A 613 ( 4.7A)NoneNone | 0.60A | 2bxgB-5dqfA:49.6 | 2bxgB-5dqfA:76.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXG_B_IBPB2002_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 7 / 10 | ALA A 209LEU A 330LEU A 346ALA A 349LYS A 350SER A 479LEU A 480 | CZE A 613 ( 4.4A)CZE A 613 ( 4.2A)CZE A 613 ( 3.8A)CZE A 613 ( 4.7A)CZE A 613 (-4.1A)NoneNone | 0.88A | 2bxgB-5dqfA:49.6 | 2bxgB-5dqfA:76.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXG_B_IBPB2002_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 5 / 10 | ARG A 208ALA A 209ALA A 212LEU A 330LEU A 346 | CZE A 613 ( 3.5A)CZE A 613 ( 4.4A)CZE A 613 ( 3.7A)CZE A 613 ( 4.2A)CZE A 613 ( 3.8A) | 0.83A | 2bxgB-5dqfA:49.6 | 2bxgB-5dqfA:76.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BXQ_A_IMNA2001_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 5 / 10 | ALA A 209ARG A 217LEU A 218LEU A 237LEU A 480 | CZE A 613 ( 4.4A) CL A 617 ( 4.6A)NonePG4 A 602 (-4.7A)None | 0.53A | 2bxqA-5dqfA:41.5 | 2bxqA-5dqfA:76.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2IZQ_A_DVAA6_0 (GRAMICIDIN D) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 3 / 3 | ALA A 481VAL A 342TRP A 213 | CZE A 613 ( 4.6A)NoneNone | 0.97A | 2izqA-5dqfA:undetectable2izqB-5dqfA:undetectable | 2izqA-5dqfA:2.292izqB-5dqfA:2.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_A_NPSA602_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 5 / 9 | ALA A 209ALA A 212LEU A 326SER A 479LEU A 480 | CZE A 613 ( 4.4A)CZE A 613 ( 3.7A)CZE A 613 ( 4.7A)NoneNone | 1.02A | 4or0A-5dqfA:50.6 | 4or0A-5dqfA:73.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_A_NPSA602_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 5 / 9 | ALA A 209LEU A 326LYS A 350SER A 479LEU A 480 | CZE A 613 ( 4.4A)CZE A 613 ( 4.7A)CZE A 613 (-4.1A)NoneNone | 1.13A | 4or0A-5dqfA:50.6 | 4or0A-5dqfA:73.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_A_NPSA602_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 5 / 9 | PHE A 205ALA A 209ALA A 212SER A 479LEU A 480 | NoneCZE A 613 ( 4.4A)CZE A 613 ( 3.7A)NoneNone | 0.89A | 4or0A-5dqfA:50.6 | 4or0A-5dqfA:73.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_A_NPSA602_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 5 / 9 | PHE A 205ARG A 208ALA A 209ALA A 212LEU A 480 | NoneCZE A 613 ( 3.5A)CZE A 613 ( 4.4A)CZE A 613 ( 3.7A)None | 0.90A | 4or0A-5dqfA:50.6 | 4or0A-5dqfA:73.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_A_NPSA603_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 5 / 11 | LEU A 197SER A 201LEU A 346LEU A 454LEU A 480 | NoneNoneCZE A 613 ( 3.8A)NoneNone | 0.95A | 4or0A-5dqfA:undetectable | 4or0A-5dqfA:73.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_B_NPSB602_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 5 / 9 | ALA A 209ALA A 212LEU A 346SER A 479LEU A 480 | CZE A 613 ( 4.4A)CZE A 613 ( 3.7A)CZE A 613 ( 3.8A)NoneNone | 0.85A | 4or0B-5dqfA:50.2 | 4or0B-5dqfA:73.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_B_NPSB602_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 5 / 9 | ALA A 209LEU A 346LYS A 350SER A 479LEU A 480 | CZE A 613 ( 4.4A)CZE A 613 ( 3.8A)CZE A 613 (-4.1A)NoneNone | 1.08A | 4or0B-5dqfA:50.2 | 4or0B-5dqfA:73.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_B_NPSB602_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 5 / 9 | ALA A 212LEU A 326LEU A 346SER A 479LEU A 480 | CZE A 613 ( 3.7A)CZE A 613 ( 4.7A)CZE A 613 ( 3.8A)NoneNone | 0.97A | 4or0B-5dqfA:50.2 | 4or0B-5dqfA:73.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_B_NPSB602_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 5 / 9 | ARG A 208ALA A 209ALA A 212LEU A 346LEU A 480 | CZE A 613 ( 3.5A)CZE A 613 ( 4.4A)CZE A 613 ( 3.7A)CZE A 613 ( 3.8A)None | 0.92A | 4or0B-5dqfA:50.2 | 4or0B-5dqfA:73.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_B_NPSB602_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 5 / 9 | LEU A 326LEU A 346LYS A 350SER A 479LEU A 480 | CZE A 613 ( 4.7A)CZE A 613 ( 3.8A)CZE A 613 (-4.1A)NoneNone | 1.02A | 4or0B-5dqfA:50.2 | 4or0B-5dqfA:73.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_B_NPSB603_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 6 / 11 | LEU A 197SER A 201VAL A 342LEU A 346LEU A 454LEU A 480 | NoneNoneNoneCZE A 613 ( 3.8A)NoneNone | 0.95A | 4or0B-5dqfA:50.2 | 4or0B-5dqfA:73.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OR0_B_NPSB603_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 5 / 11 | SER A 201VAL A 342SER A 343LEU A 346LEU A 480 | NoneNoneNoneCZE A 613 ( 3.8A)None | 0.90A | 4or0B-5dqfA:50.2 | 4or0B-5dqfA:73.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OT2_A_NPSA602_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 4 / 6 | ALA A 212ASP A 323LEU A 346LYS A 350 | CZE A 613 ( 3.7A)CZE A 613 ( 4.7A)CZE A 613 ( 3.8A)CZE A 613 (-4.1A) | 1.05A | 4ot2A-5dqfA:54.7 | 4ot2A-5dqfA:99.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OT2_A_NPSA602_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 4 / 6 | ALA A 212ASP A 323LEU A 346SER A 479 | CZE A 613 ( 3.7A)CZE A 613 ( 4.7A)CZE A 613 ( 3.8A)None | 0.61A | 4ot2A-5dqfA:54.7 | 4ot2A-5dqfA:99.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OT2_A_NPSA602_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 4 / 6 | ARG A 208ALA A 212LEU A 346SER A 479 | CZE A 613 ( 3.5A)CZE A 613 ( 3.7A)CZE A 613 ( 3.8A)None | 0.94A | 4ot2A-5dqfA:54.7 | 4ot2A-5dqfA:99.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZBR_A_NPSA603_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 8 / 10 | ALA A 212ASP A 323LEU A 326LEU A 346ALA A 349SER A 479LEU A 480ALA A 481 | CZE A 613 ( 3.7A)CZE A 613 ( 4.7A)CZE A 613 ( 4.7A)CZE A 613 ( 3.8A)CZE A 613 ( 4.7A)NoneNoneCZE A 613 ( 4.6A) | 0.40A | 4zbrA-5dqfA:55.4 | 4zbrA-5dqfA:99.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZBR_A_NPSA603_1 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 6 / 10 | ARG A 208ALA A 212LEU A 346SER A 479LEU A 480ALA A 481 | CZE A 613 ( 3.5A)CZE A 613 ( 3.7A)CZE A 613 ( 3.8A)NoneNoneCZE A 613 ( 4.6A) | 0.83A | 4zbrA-5dqfA:55.4 | 4zbrA-5dqfA:99.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6MDQ_A_TESA604_0 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 4 / 8 | LEU A 330ALA A 349LYS A 350GLU A 353 | CZE A 613 ( 4.2A)CZE A 613 ( 4.7A)CZE A 613 (-4.1A)CZE A 613 (-2.9A) | 0.69A | 6mdqA-5dqfA:55.4 | 6mdqA-5dqfA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6MDQ_A_TESA604_0 (SERUM ALBUMIN) |
5dqf | SERUM ALBUMIN (Equuscaballus) | 6 / 8 | LYS A 211ALA A 212GLY A 327LEU A 330ALA A 349GLU A 353 | NoneCZE A 613 ( 3.7A)CZE A 613 (-3.5A)CZE A 613 ( 4.2A)CZE A 613 ( 4.7A)CZE A 613 (-2.9A) | 0.47A | 6mdqA-5dqfA:55.4 | 6mdqA-5dqfA:100.00 |